Uncategorized - June 22, 2020
BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug […]
Read More
Uncategorized - June 22, 2020
COLUMBIA, Md., June 22, 2020 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ:REKR) (“Rekor”) (“the Company”), a Maryland-based company providing real-time […]
Read More
Uncategorized - June 22, 2020
REDWOOD CITY, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on […]
Read More
Uncategorized - June 22, 2020
NEW YORK and TORONTO, June 22, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
Read More
Uncategorized - June 22, 2020
Update Provided Phase I Study of MT-5111 in HER2-positive CancersConference Call and Webcast to Discuss AACR Posters on June 25th […]
Read More
Uncategorized - June 22, 2020
TROY, Mich., June 22, 2020 (GLOBE NEWSWIRE) — Kelly, a global leader in providing workforce solutions, today announced the appointment […]
Read More
Uncategorized - June 22, 2020
Peptide-drug conjugates TH1902 and TH1904 show significant reduction in the formation of vasculogenic mimicry by targeting the sortilin receptorCurcumin shows […]
Read More
Uncategorized - June 22, 2020
RICHMOND HILL, Ontario, June 22, 2020 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology […]
Read More
Uncategorized - June 22, 2020
Interim data demonstrate that HB‑101 is well toleratedHB-101 elicits T cell and B cell responses in the target populationNEW YORK […]
Read More
Uncategorized - June 22, 2020
SAN JOSE, Calif., June 22, 2020 (GLOBE NEWSWIRE) — Zscaler, Inc. (Nasdaq: ZS) today announced that it intends to offer $1.0 […]
Read More